Vcgt
Kobe, JP · 1 known investors
VC Gene Therapy develops gene therapies, with a first pipeline using genome editing to treat autosomal dominant inherited retinal degenerative diseases and aiming to begin clinical trials. It is a subsidiary of Vision Care Inc. and part of the Vision Care Group, based in Kobe, Japan.
Founders & leadership
MT
Masashiro Takahashi
MT
Masayo TakahashiPresident & CEO (代表取締役社長 CEO)
TF
Takuma FukudaDirector & CFO (取締役 CFO)
YN
Yoshinori NishikawaAuditor (監査役)
Board
YI
Yuji InomataDirector (取締役)
TC
Tsuyoshi ChiwataOutside Director (社外取締役)
Investors · 1
Frequently asked questions
- What does Vcgt do?
- VC Gene Therapy develops gene therapies, with a first pipeline using genome editing to treat autosomal dominant inherited retinal degenerative diseases and aiming to begin clinical trials. It is a subsidiary of Vision Care Inc. and part of the Vision Care Group, based in Kobe, Japan.
- Who founded Vcgt?
- Vcgt was founded by Masashiro Takahashi.
- Who are Vcgt's investors?
- Vcgt's investors include Kobe University Capital.
- Where is Vcgt headquartered?
- Vcgt is headquartered in Kobe, JP.